Plain-English translation of NCT04947254 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether adding a drug called to standard prostate cancer treatment—hormone therapy and radiation—works better than hormone therapy and radiation alone. The trial focuses on men whose cancer has spread to nearby lymph nodes or has other high-risk features, and whose tumors didn't respond well enough to initial hormone therapy. Researchers want to see if the medication helps prevent the cancer from coming back or spreading.
Some men with advanced prostate cancer don't respond well enough to standard hormone therapy alone, and their cancer can return after treatment. This trial is testing whether adding this medication might help stop cancer cells from coming back and improve survival for these men.
You likely qualify if…
You likely don't qualify if…
You will participate in three phases over approximately one year or more. First, you'll take hormone-blocking medications by mouth daily for three months. Then you'll receive radiation therapy over several weeks while continuing these medications. Finally, you'll continue hormone therapy (with half the participants also taking the new medication ) for up to a year. Throughout the study, you'll have regular clinic visits for blood tests, imaging, and check-ins to monitor how you're responding and watch for side effects. You'll also provide tissue and blood samples for research to help doctors understand which patients benefit most from this approach.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States